Report cover image

Global Amlodipine Besylate Tablets Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 103 Pages
SKU # APRC20354982

Description

Summary

According to APO Research, The global Amlodipine Besylate Tablets market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Amlodipine Besylate Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Amlodipine Besylate Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Amlodipine Besylate Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Amlodipine Besylate Tablets include AstraZeneca, Bristol-Myers Squibb, North China Pharmaceutical, China Resources Double-Crane Pharmaceutical, Pfizer, Jingfeng Pharmaceutical, Roche, Sanofi and Shanghai Shyndec Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Amlodipine Besylate Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amlodipine Besylate Tablets.

The Amlodipine Besylate Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Amlodipine Besylate Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Amlodipine Besylate Tablets Segment by Company

AstraZeneca
Bristol-Myers Squibb
North China Pharmaceutical
China Resources Double-Crane Pharmaceutical
Pfizer
Jingfeng Pharmaceutical
Roche
Sanofi
Shanghai Shyndec Pharmaceutical
Yangtze River Pharmaceutical

Amlodipine Besylate Tablets Segment by Type

5 Milligrams
10 Milligrams

Amlodipine Besylate Tablets Segment by Application

Hospital
Pharmacy

Amlodipine Besylate Tablets Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amlodipine Besylate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amlodipine Besylate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amlodipine Besylate Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amlodipine Besylate Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Amlodipine Besylate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Table of Contents

103 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Amlodipine Besylate Tablets Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Amlodipine Besylate Tablets Sales Estimates and Forecasts (2020-2031)
1.3 Amlodipine Besylate Tablets Market by Type
1.3.1 5 Milligrams
1.3.2 10 Milligrams
1.4 Global Amlodipine Besylate Tablets Market Size by Type
1.4.1 Global Amlodipine Besylate Tablets Market Size Overview by Type (2020-2031)
1.4.2 Global Amlodipine Besylate Tablets Historic Market Size Review by Type (2020-2025)
1.4.3 Global Amlodipine Besylate Tablets Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Amlodipine Besylate Tablets Sales Breakdown by Type (2020-2025)
1.5.2 Europe Amlodipine Besylate Tablets Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Amlodipine Besylate Tablets Sales Breakdown by Type (2020-2025)
1.5.4 South America Amlodipine Besylate Tablets Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Amlodipine Besylate Tablets Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Amlodipine Besylate Tablets Industry Trends
2.2 Amlodipine Besylate Tablets Industry Drivers
2.3 Amlodipine Besylate Tablets Industry Opportunities and Challenges
2.4 Amlodipine Besylate Tablets Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Amlodipine Besylate Tablets Revenue (2020-2025)
3.2 Global Top Players by Amlodipine Besylate Tablets Sales (2020-2025)
3.3 Global Top Players by Amlodipine Besylate Tablets Price (2020-2025)
3.4 Global Amlodipine Besylate Tablets Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Amlodipine Besylate Tablets Major Company Production Sites & Headquarters
3.6 Global Amlodipine Besylate Tablets Company, Product Type & Application
3.7 Global Amlodipine Besylate Tablets Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Amlodipine Besylate Tablets Market CR5 and HHI
3.8.2 Global Top 5 and 10 Amlodipine Besylate Tablets Players Market Share by Revenue in 2024
3.8.3 2023 Amlodipine Besylate Tablets Tier 1, Tier 2, and Tier 3
4 Amlodipine Besylate Tablets Regional Status and Outlook
4.1 Global Amlodipine Besylate Tablets Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Amlodipine Besylate Tablets Historic Market Size by Region
4.2.1 Global Amlodipine Besylate Tablets Sales in Volume by Region (2020-2025)
4.2.2 Global Amlodipine Besylate Tablets Sales in Value by Region (2020-2025)
4.2.3 Global Amlodipine Besylate Tablets Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Amlodipine Besylate Tablets Forecasted Market Size by Region
4.3.1 Global Amlodipine Besylate Tablets Sales in Volume by Region (2026-2031)
4.3.2 Global Amlodipine Besylate Tablets Sales in Value by Region (2026-2031)
4.3.3 Global Amlodipine Besylate Tablets Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Amlodipine Besylate Tablets by Application
5.1 Amlodipine Besylate Tablets Market by Application
5.1.1 Hospital
5.1.2 Pharmacy
5.2 Global Amlodipine Besylate Tablets Market Size by Application
5.2.1 Global Amlodipine Besylate Tablets Market Size Overview by Application (2020-2031)
5.2.2 Global Amlodipine Besylate Tablets Historic Market Size Review by Application (2020-2025)
5.2.3 Global Amlodipine Besylate Tablets Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Amlodipine Besylate Tablets Sales Breakdown by Application (2020-2025)
5.3.2 Europe Amlodipine Besylate Tablets Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Amlodipine Besylate Tablets Sales Breakdown by Application (2020-2025)
5.3.4 South America Amlodipine Besylate Tablets Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Amlodipine Besylate Tablets Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 AstraZeneca
6.1.1 AstraZeneca Comapny Information
6.1.2 AstraZeneca Business Overview
6.1.3 AstraZeneca Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca Amlodipine Besylate Tablets Product Portfolio
6.1.5 AstraZeneca Recent Developments
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Comapny Information
6.2.2 Bristol-Myers Squibb Business Overview
6.2.3 Bristol-Myers Squibb Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bristol-Myers Squibb Amlodipine Besylate Tablets Product Portfolio
6.2.5 Bristol-Myers Squibb Recent Developments
6.3 North China Pharmaceutical
6.3.1 North China Pharmaceutical Comapny Information
6.3.2 North China Pharmaceutical Business Overview
6.3.3 North China Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 North China Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
6.3.5 North China Pharmaceutical Recent Developments
6.4 China Resources Double-Crane Pharmaceutical
6.4.1 China Resources Double-Crane Pharmaceutical Comapny Information
6.4.2 China Resources Double-Crane Pharmaceutical Business Overview
6.4.3 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
6.4.5 China Resources Double-Crane Pharmaceutical Recent Developments
6.5 Pfizer
6.5.1 Pfizer Comapny Information
6.5.2 Pfizer Business Overview
6.5.3 Pfizer Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Amlodipine Besylate Tablets Product Portfolio
6.5.5 Pfizer Recent Developments
6.6 Jingfeng Pharmaceutical
6.6.1 Jingfeng Pharmaceutical Comapny Information
6.6.2 Jingfeng Pharmaceutical Business Overview
6.6.3 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
6.6.5 Jingfeng Pharmaceutical Recent Developments
6.7 Roche
6.7.1 Roche Comapny Information
6.7.2 Roche Business Overview
6.7.3 Roche Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Roche Amlodipine Besylate Tablets Product Portfolio
6.7.5 Roche Recent Developments
6.8 Sanofi
6.8.1 Sanofi Comapny Information
6.8.2 Sanofi Business Overview
6.8.3 Sanofi Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sanofi Amlodipine Besylate Tablets Product Portfolio
6.8.5 Sanofi Recent Developments
6.9 Shanghai Shyndec Pharmaceutical
6.9.1 Shanghai Shyndec Pharmaceutical Comapny Information
6.9.2 Shanghai Shyndec Pharmaceutical Business Overview
6.9.3 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
6.9.5 Shanghai Shyndec Pharmaceutical Recent Developments
6.10 Yangtze River Pharmaceutical
6.10.1 Yangtze River Pharmaceutical Comapny Information
6.10.2 Yangtze River Pharmaceutical Business Overview
6.10.3 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
6.10.5 Yangtze River Pharmaceutical Recent Developments
7 North America by Country
7.1 North America Amlodipine Besylate Tablets Sales by Country
7.1.1 North America Amlodipine Besylate Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Amlodipine Besylate Tablets Sales by Country (2020-2025)
7.1.3 North America Amlodipine Besylate Tablets Sales Forecast by Country (2026-2031)
7.2 North America Amlodipine Besylate Tablets Market Size by Country
7.2.1 North America Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Amlodipine Besylate Tablets Market Size by Country (2020-2025)
7.2.3 North America Amlodipine Besylate Tablets Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Amlodipine Besylate Tablets Sales by Country
8.1.1 Europe Amlodipine Besylate Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Amlodipine Besylate Tablets Sales by Country (2020-2025)
8.1.3 Europe Amlodipine Besylate Tablets Sales Forecast by Country (2026-2031)
8.2 Europe Amlodipine Besylate Tablets Market Size by Country
8.2.1 Europe Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Amlodipine Besylate Tablets Market Size by Country (2020-2025)
8.2.3 Europe Amlodipine Besylate Tablets Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Amlodipine Besylate Tablets Sales by Country
9.1.1 Asia-Pacific Amlodipine Besylate Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Amlodipine Besylate Tablets Sales by Country (2020-2025)
9.1.3 Asia-Pacific Amlodipine Besylate Tablets Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Amlodipine Besylate Tablets Market Size by Country
9.2.1 Asia-Pacific Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Amlodipine Besylate Tablets Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Amlodipine Besylate Tablets Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Amlodipine Besylate Tablets Sales by Country
10.1.1 South America Amlodipine Besylate Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Amlodipine Besylate Tablets Sales by Country (2020-2025)
10.1.3 South America Amlodipine Besylate Tablets Sales Forecast by Country (2026-2031)
10.2 South America Amlodipine Besylate Tablets Market Size by Country
10.2.1 South America Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Amlodipine Besylate Tablets Market Size by Country (2020-2025)
10.2.3 South America Amlodipine Besylate Tablets Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Amlodipine Besylate Tablets Sales by Country
11.1.1 Middle East and Africa Amlodipine Besylate Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Amlodipine Besylate Tablets Sales by Country (2020-2025)
11.1.3 Middle East and Africa Amlodipine Besylate Tablets Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Amlodipine Besylate Tablets Market Size by Country
11.2.1 Middle East and Africa Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Amlodipine Besylate Tablets Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Amlodipine Besylate Tablets Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Amlodipine Besylate Tablets Value Chain Analysis
12.1.1 Amlodipine Besylate Tablets Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Amlodipine Besylate Tablets Production Mode & Process
12.2 Amlodipine Besylate Tablets Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Amlodipine Besylate Tablets Distributors
12.2.3 Amlodipine Besylate Tablets Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.